Summary:
Seeking volunteers to participate in an Eczema (Atopic Dermatitis) study for those whose current medication is not adequately treating their Eczema (AD). A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy on particpants aged 18 years and older with moderate-to severe atopic dermatitis.
Criteria:- Be 18 years of age
- Diagnosed with Eczema (Atopic Dermatitis) for at least 6 months
- Have at least 7% of their body affected by the condition
Qualified Participants May Receive:
- Compensation for time and travel up to $3,000
- No cost medical assessments
- No cost inhalers for the duration of the study